{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:17:58Z","timestamp":1789179478083,"version":"build-2803163510"},"reference-count":140,"publisher":"SAGE Publications","issue":"s1","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Alzheimer\u2019s Disease"],"published-print":{"date-parts":[[2024,10,18]]},"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is a progressive neurological disorder characterized by memory loss, cognitive decline, and behavioral changes. Immunotherapy aims to harness the immune system to target the underlying pathology of AD and has shown promise as a disease-modifying treatment for AD. By focusing on the underlying disease pathogenesis and encouraging the removal of abnormal protein aggregates in the brain, immunotherapy shows promise as a potential treatment for AD. The development of immunotherapy for AD began with early attempts to use antibodies to target beta-amyloid. The amyloid hypothesis which suggests that the accumulation of beta-amyloid in the brain triggers the pathological cascade that leads to AD has been a driving force behind the development of immunotherapy for AD. However, recent clinical trials of monoclonal antibodies targeting amyloid-\u03b2 have shown mixed results, highlighting the need for further research into alternative immunotherapy approaches. Additionally, the safety and efficacy of immunotherapy for AD remain an area of active investigation. Some immunotherapeutic approaches have shown promise, while others have been associated with significant side effects, including inflammation of the brain. Sleep has a significant impact on various physiological processes, including the immune system, and has been linked to the pathogenesis of AD. Thus, improving sleep quality and duration may benefit the immune system and potentially enhance the effectiveness of immunotherapeutic approaches for AD. In this review, we discussed the promises of immunotherapy as a disease-modifying treatment for AD as well as possible methods to improve the efficacy and safety of immunotherapy to achieve better therapeutic outcomes.<\/jats:p>","DOI":"10.3233\/jad-230603","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T10:50:46Z","timestamp":1729248646000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":13,"title":["Immunotherapy in Alzheimer\u2019s Disease: Current Status and Future Directions"],"prefix":"10.1177","volume":"101","author":[{"given":"Kshitij","family":"Vashisth","sequence":"first","affiliation":[{"name":"GloNeuro, Noida, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Sharma","sequence":"additional","affiliation":[{"name":"R.K.S.D. College of Pharmacy","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shampa","family":"Ghosh","sequence":"additional","affiliation":[{"name":"GloNeuro, Noida, India"},{"name":"ICMR \u2013 National Institute of Nutrition","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Arockia","family":"Babu","sequence":"additional","affiliation":[{"name":"GLA University","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Ghosh","sequence":"additional","affiliation":[{"name":"GloNeuro, Noida, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danish","family":"Iqbal","sequence":"additional","affiliation":[{"name":"College of Applied Medical Sciences","place":["Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehnaz","family":"Kamal","sequence":"additional","affiliation":[{"name":"Prince Sattam Bin Abdulaziz University","place":["Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmajeed G.","family":"Almutary","sequence":"additional","affiliation":[{"name":"Abu Dhabi University","place":["United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh Kumar","family":"Jha","sequence":"additional","affiliation":[{"name":"University of Delhi","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreesh","family":"Ojha","sequence":"additional","affiliation":[{"name":"United Arab Emirates University","place":["United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Bhaskar","sequence":"additional","affiliation":[{"name":"Yeungnam University","place":["Korea"]},{"name":"Yeungnam University","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj Kumar","family":"Jha","sequence":"additional","affiliation":[{"name":"Saveetha University","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra Kumar","family":"Sinha","sequence":"additional","affiliation":[{"name":"GloNeuro, Noida, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Association (2020) 2020 Alzheimer\u2019s disease facts and figures. Alzheimers Dement16 391\u2013460.","DOI":"10.1002\/alz.12068"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-019-0478-5"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleepe.2022.100049"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12050"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2018.03.007"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00010.2018"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2014.12.064"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X18666200429011823"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-019-0609-7"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-017-0283-5"},{"key":"e_1_3_4_12_2","first-page":"1019","article-title":"SIRT1 promotes neuronal fortification in neurodegenerative diseases through attenuation of pathological hallmarks and enhancement of cellular lifespan","volume":"19","author":"Mishra P","year":"2021","unstructured":"MishraP, MittalAK, KaloniaH, MadanS, GhoshS, SinhaJK, RajputSK (2021) SIRT1 promotes neuronal fortification in neurodegenerative diseases through attenuation of pathological hallmarks and enhancement of cellular lifespan. Curr Neuropharmacol19, 1019\u20131037.","journal-title":"Curr Neuropharmacol"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00032.2012"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleepx.2022.100049"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1241224"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2021.113400"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2013.269"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/22124"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/35050116"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(03)00294-0"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2004.07.012"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304839"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000073623.84147.A8"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000159740.16984.3C"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature19323"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312889"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14050987"},{"key":"e_1_3_4_28_2","first-page":"151","article-title":"Drug delivery strategies to overcome the blood\u2013brain barrier (BBB)","author":"Helms HCC","year":"2022","unstructured":"HelmsHCC, KristensenM, SaabyL, FrickerG, BrodinB (2022) Drug delivery strategies to overcome the blood\u2013brain barrier (BBB). In Physiology, Pharmacology and Pathology of the Blood-Brain Barrier. CaderZ, NeuhausW, eds. Springer International Publishing, Cham, pp. 151\u2013183.","journal-title":"Physiology, Pharmacology and Pathology of the Blood-Brain Barrier"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2011-110977"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.1538"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00663-w"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2023.2178414"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2010.07568.x"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.03.035"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv326"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1074069"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.2174\/1567205011310030001"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003904"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/nn842"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2014.935332"},{"key":"e_1_3_4_41_2","unstructured":"Johnson & Johnson (2012) Johnson & Johnson Announces Discontinuation Of Phase 3 Development of Bapineuzumab Intravenous (IV) In Mild-To-Moderate Alzheimer\u2019s Disease. https:\/\/www.jnj.com\/media-center\/press-releases\/johnson-johnson-announces-discontinuation-of-phase-3-development-of-bapineuzumab-intravenous-iv-in-mild-to-moderate-alzheimers-disease"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705971"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2003.12.020"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1072994"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00025"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.2741\/s149"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0079-7"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt269"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/s42823-022-00397-9"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.3390\/biom12071001"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12213"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70140-0"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.3.1580"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2017.03.005"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-180766"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108352"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0205-1"},{"key":"e_1_3_4_58_2","article-title":"Aducanumab","author":"Padda IS","year":"2021","unstructured":"PaddaIS, ParmarM (2021) Aducanumab. In StatPearls [Internet]. Treasure Island (FL).","journal-title":"StatPearls [Internet]"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30480-6"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-017-0318-y"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-022-01308-6"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2015.06.1893"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12223"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2100708"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.2793"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2010.493872"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.2174\/9781681080680115030004"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1002\/pep2.24289"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1665453"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200724020-00003"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.3390\/antib12020041"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-022-01201-2"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112841"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10790-5"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-022-01236-5"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2018.03.009"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2022.30"},{"key":"e_1_3_4_78_2","first-page":"9343514","article-title":"Aducanumab therapy to treat Alzheimer\u2019s disease: A narrative review","volume":"2022","author":"Beshir SA","year":"2022","unstructured":"BeshirSA, AadithsooryaAM, ParveenA, GohSSL, HussainN, MenonVB (2022) Aducanumab therapy to treat Alzheimer\u2019s disease: A narrative review. Int J Alzheimers Dis2022, 9343514.","journal-title":"Int J Alzheimers Dis"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.4604"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal2029"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-215270"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01084-X"},{"key":"e_1_3_4_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.02.007"},{"key":"e_1_3_4_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.02.004"},{"key":"e_1_3_4_85_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12422"},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12168"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2896"},{"key":"e_1_3_4_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01124-1"},{"key":"e_1_3_4_89_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.4161"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trci.2018.02.002"},{"key":"e_1_3_4_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2013.07.046"},{"key":"e_1_3_4_92_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.11.6448"},{"key":"e_1_3_4_93_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1079469"},{"key":"e_1_3_4_94_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00813-8"},{"key":"e_1_3_4_95_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq0095"},{"key":"e_1_3_4_96_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-201334"},{"key":"e_1_3_4_97_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab465"},{"key":"e_1_3_4_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2012.09.008"},{"key":"e_1_3_4_99_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-190484"},{"key":"e_1_3_4_100_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn.2015.1"},{"key":"e_1_3_4_101_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00292-3"},{"key":"e_1_3_4_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2022.03.203"},{"key":"e_1_3_4_103_2","doi-asserted-by":"publisher","DOI":"10.4161\/auto.19048"},{"key":"e_1_3_4_104_2","doi-asserted-by":"publisher","DOI":"10.1038\/256495a0"},{"key":"e_1_3_4_105_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1837"},{"key":"e_1_3_4_106_2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.176"},{"key":"e_1_3_4_107_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019338"},{"key":"e_1_3_4_108_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2755-14.2014"},{"key":"e_1_3_4_109_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01986"},{"key":"e_1_3_4_110_2","doi-asserted-by":"publisher","DOI":"10.1093\/occmed\/kqm110"},{"key":"e_1_3_4_111_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.31.060407.125529"},{"key":"e_1_3_4_112_2","doi-asserted-by":"publisher","DOI":"10.3390\/biology9120425"},{"key":"e_1_3_4_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-415847-4.00071-9"},{"key":"e_1_3_4_114_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri2744"},{"key":"e_1_3_4_115_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.406"},{"key":"e_1_3_4_116_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13167-017-0101-y"},{"key":"e_1_3_4_117_2","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2017.0112"},{"key":"e_1_3_4_118_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0013-z"},{"key":"e_1_3_4_119_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171484"},{"key":"e_1_3_4_120_2","first-page":"243","article-title":"PRECISION MEDICINE \u2013 The golden gate for detection, treatment and prevention of Alzheimer\u2019s disease","volume":"3","author":"Hampel H","year":"2016","unstructured":"HampelH, O\u2019BryantSE, CastrilloJI, RitchieC, RojkovaK, BroichK, BendaN, Nistic\u00f2R, FrankRA, DuboisB, Escott-PriceV, ListaS (2016) PRECISION MEDICINE \u2013 The golden gate for detection, treatment and prevention of Alzheimer\u2019s disease. J Prev Alzheimers Dis3, 243\u2013259.","journal-title":"J Prev Alzheimers Dis"},{"key":"e_1_3_4_121_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-019-0463-z"},{"key":"e_1_3_4_122_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2008.08.002"},{"key":"e_1_3_4_123_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.0049"},{"key":"e_1_3_4_124_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-psych-010213-115205"},{"key":"e_1_3_4_125_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20181169"},{"key":"e_1_3_4_126_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.05300.x"},{"key":"e_1_3_4_127_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2014.03.035"},{"key":"e_1_3_4_128_2","first-page":"Cd010633","article-title":"Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies","volume":"1","author":"McCleery J","year":"2015","unstructured":"McCleeryJ, MorganS, BradleyKM, Noel-StorrAH, AnsorgeO, HydeC (2015) Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies. Cochrane Database Syst Rev1, Cd010633.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_129_2","doi-asserted-by":"publisher","DOI":"10.4103\/1463-1741.104897"},{"key":"e_1_3_4_130_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2017.12.002"},{"key":"e_1_3_4_131_2","doi-asserted-by":"publisher","DOI":"10.3109\/07420528.2013.793196"},{"key":"e_1_3_4_132_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2015.10.016"},{"key":"e_1_3_4_133_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcm.2008.09.002"},{"key":"e_1_3_4_134_2","doi-asserted-by":"publisher","DOI":"10.1080\/07420520500263276"},{"key":"e_1_3_4_135_2","doi-asserted-by":"publisher","DOI":"10.1002\/iub.1532"},{"key":"e_1_3_4_136_2","doi-asserted-by":"publisher","DOI":"10.1177\/1179573520907397"},{"key":"e_1_3_4_137_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2012-120640"},{"key":"e_1_3_4_138_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2015.07.002"},{"key":"e_1_3_4_139_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00574-4"},{"key":"e_1_3_4_140_2","doi-asserted-by":"publisher","DOI":"10.3390\/life12101673"},{"key":"e_1_3_4_141_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_2120_18"}],"container-title":["Journal of Alzheimer\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JAD-230603","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.3233\/JAD-230603","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JAD-230603","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:59:13Z","timestamp":1777370353000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3233\/JAD-230603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":140,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2024,10,18]]}},"alternative-id":["10.3233\/JAD-230603"],"URL":"https:\/\/doi.org\/10.3233\/jad-230603","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]}}}